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Abstract
Background: Bartonella vinsonii subsp. berkhoffii is an important, emerging, intravascular bacterial pathogen that
has been recently isolated from immunocompetent patients with endocarditis, arthritis, neurological disease and
vasoproliferative neoplasia. Vector transmission is suspected among dogs and wild canines, which are the primary
reservoir hosts. This investigation was initiated to determine if pets and family members were infected with one or
more Bartonella species.
Methods: PCR and enrichment blood culture in Bartonella alpha Proteobacteria growth medium (BAPGM) was
used to determine infection status. Antibody titers to B. vinsonii subsp. berkhoffii genotypes I-III and B. henselae
were determined using a previously described indirect fluorescent antibody test. Two patients were tested
sequentially for over a year to assess the response to antibiotic treatment.
Results: Intravascular infection with B. vinsonii subsp. berkhoffii genotype II and Bartonella henselae (Houston 1
strain) were confirmed in a veterinarian and his daughter by enrichment blood culture, followed by PCR and DNA
sequencing. Symptoms included progressive weight loss, muscle weakness, lack of coordination (the father) and
headaches, muscle pain and insomnia (the daughter). B. vinsonii subsp. berkhoffii genotype II was also sequenced
from a cerebrospinal fluid BAPGM enrichment culture and from a periodontal swab sample. After repeated courses
of antibiotics, post-treatment blood cultures were negative, there was a decremental decrease in antibody titers to
non-detectable levels and symptoms resolved in both patients.
Conclusions: B. vinsonii subsp. berkhoffii and B. henselae are zoonotic pathogens that can be isolated from the
blood of immunocompetent family members with arthralgias, fatigue and neurological symptoms. Therapeutic
elimination of Bartonella spp. infections can be challenging, and follow-up testing is recommended. An increasing
number of arthropod vectors, including biting flies, fleas, keds, lice, sandflies and ticks have been confirmed or are
suspected as the primary mode of transmission of Bartonella species among animal populations and may also pose
a risk to human beings.
Background
When a genus of bacteria is discovered or, in the case of
Bartonella, rediscovered; numerous clinical, microbiolo-
gical and pathological concepts related to disease causa-
tion and microbial pathogenesis are sequentially
redefined. Subsequently, the medical relevance of the
genus undergoes continued maturation; as knowledge of
the organism, the host immune response, diagnostic test
sensitivity and specificity, treatment efficacy and epide-
miology expand. Since the early 1990s, this paradigm of
discovery and ongoing biological and medical redefini-
tion has clearly been applicable to the genus Bartonella.
Prior to 1990, only two pathogenic Bartonella species,
B. bacilliformis and B. quintana, were known to exist.
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cated or confirmed as human pathogens [1,2].
Bartonella vinsonii subsp. berkhoffii was initially iso-
lated from a dog with endocarditis in 1993 [3]. Subse-
quently, four genotypes of B. vinsonii subsp. berkhoffii
were described, based upon analysis of blood samples
from coyotes, dogs and foxes [4]. To date, genotype II
has been the most frequently isolated genotype
s e q u e n c e df r o md o ga n dh u m a nb l o o ds a m p l e s[ 5 - 8 ] .
Previously, B. vinsonii subsp. berkhoffii genotype II was
documented in a healthy dog on 8 of 10 culture
attempts spanning a 16-month period, thereby support-
ing the potential for persistent intravascular infection in
pet dogs [9]. Although tick transmission of B. vinsonii
subsp. berkhoffii has been suggested, the mode(s) of
transmission among canines has not been determined
[10]. In contrast to the canine reservoir for B. vinsonii
subsp. berkhoffii, domestic and wild felids represent the
primary reservoir in nature for Bartonella henselae,a n
organism transmitted among cats by fleas (Ctenocepha-
lides felis); a factor that contributes to a worldwide dis-
tribution for this Bartonella sp. [1,2]. Similar to dogs,
outwardly healthy cats can remain bacteremic with B.
henselae for months to years [11,12]. However, despite
what seems to be exceptional evolutionary adaptation of
B. vinsonii subsp. berkhoffii in canines and B. henselae
in felines, both of these two bacterial species can be
pathogenic in both cats and dogs.
In this study, intravascular infection with B. vinsonii
subsp. berkhoffii genotype II and B. henselae were foun-
din a veterinarian and his daughter. The father pre-
sented with progressive weight loss, muscle weakness
and lack of coordination; his daughter had developed
headaches, muscle pain and insomnia. Both individuals
w e r eb e i n ge v a l u a t e db yan e u r o l o g i s ta tt h et i m eo f
initial testing for evidence of Bartonella infection. Multi-
ple courses of antibiotics were administered before the
patients’ clinical status improved and before microbiolo-
gical, molecular and serological evidence of infection
diminished or was negative.
Patients, pets and methods
In October, 2007, the primary author was contacted by
the father of a family residing in North Carolina, who
requested Bartonella testing as a component of an IRB
approved study (North Carolina State University Institu-
tional Review Board, IRB#s 4925-03 and 164-08-05). For
all family members and pets (Institutional Animal Care
and Use Protocol 07-014-0) tested in this study, a pre-
viously described approach that combines PCR detection
of Bartonella spp. DNA and enrichment culture of
blood and serum samples in Bartonella alpha Proteobac-
teria growth medium (BAPGM) was used [8]. The three
part BAPGM diagnostic platform incorporates PCR
amplification of Bartonella spp. following direct DNA
extraction from patient blood and serum samples, PCR
amplification following enrichment culture in BAPGM
for 7 to 14 days, and PCR from isolates obtained follow-
ing BAPGM subculture inoculation onto trypticase soy
agar with 10% rabbit blood. Agar plates are incubated
for 4 weeks and checked weekly for evidence of bacterial
growth. To assess for potential laboratory contamina-
tion, an un-inoculated BAPGM culture flask was pro-
cessed simultaneously and in an identical manner with
each batch of patient blood and serum samples tested.
Specifically, while establishing cultures using a batch of
samples in the biosafety hood, the top was removed
from the BAPGM un-inoculated control flask until all
patient samples had been processed. Methods used for
testing sample cultures, including DNA extraction, PCR
amplification targeting the Bartonella 16S-23S intergenic
spacer region (ITS), and sequencing procedures were
performed using previously described methods [5-8].
Following the standard operating procedures in the
Intracellular Pathogens Research Laboratory, sample
preparation including BAPGM cultures and agar plate
sub-inoculation, DNA extraction, PCR preparation and
PCR amplification and analysis were performed in sepa-
rate laboratory rooms to avoid culture as well as DNA
contamination. In addition, negative and positive Barto-
nella DNA test control samples, consisting of bacteria-
free blood DNA and DNA spiked with B. henselae geno-
mic DNA at 0.5 genome copies per microliter, respec-
tively, were used for each batch of DNA tested. For all
results reported in this study, PCR products consistent
in size with a Bartonella spp. (400-600 bp amplicon
size) were sequenced to confirm the species and ITS
strain. Sequences were aligned and compared with Gen-
Bank sequences using AlignX software (Vector NTI
Suite 6.0, InforMax, Inc.).
Serology was performed using modifications of a pre-
viously described indirect fluorescent antibody test [13].
Bartonella vinsonii subsp. berkhoffii and B. henselae
antibodies were determined following traditional immu-
nofluorescence antibody assay (IFA) practices with fluor-
escein conjugated goat anti-human IgG. Bartonella
vinsonii subsp. berkhoffii genotypes I, II and III and B.
henselae (Houston I strain) were passed from agar
grown cultures of each organism into DH82 (a continu-
ous canine histiocytic cell line) cultures to obtain anti-
gens that would seemingly be expressed by an
intracellular bacteria localized to erythrocytes or
endothelial cells within the vasculature. Heavily infected
cell cultures were spotted onto 30-well Teflon coated
slides (Cel-Line/Thermo Scientific), air dried, acetone
fixed and stored frozen. Serum samples were diluted in
phosphate buffered saline (PBS) solution containing nor-
mal goat serum, Tween-20 and powdered nonfat dry
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sera were screened at dilutio n so f1 : 1 6t o1 : 6 4 .A l ls e r a
that remained reactive at a titer of 1:64 were further
tested with twofold dilutions out to a final dilution of
1:8192.
Results
Father
The father was a 50-year-old veterinarian whose symp-
toms began in 2006 with arthralgias and fatigue, which
became progressively severe over ensuing 18 months.
He described pain and stiffness of the joints, muscles,
and neck that were most severe in the morning but
improved throughout the day. He did not have fevers,
b u th es u f f e r e df r o mp r o f o u n df a t i g u e .H eh a da l s o
experienced an 80-pound weight loss, though this was
partially intentional. Beginning in September 2007, and
of greatest concern to the patient, was progressive diffi-
culty maintaining his balance while standing or ambulat-
ing. His history was notable for extensive occupational
and domestic animal exposure. International travel was
minimal. He was initially evaluated by a neurologist, and
because of his exposure to zoonotic pathogens he was
referred for infectious disease evaluation. He had not
received any empiric courses of antibiotics.
On physical examination, the patient had a blood
pressure of 141/88 mm Hg, a pulse of 98 beats/min, and
a temperature of 37°C. He was in no acute distress and
had a normal sensorium. Notable abnormal findings
included a positive Romberg sign and difficulty with
heel-toe walking. Cranial nerves, muscle strength, sensa-
tion, and deep tendon reflexes were normal and symme-
trical, and his funduscopic examination was normal.
There was no lymphadenopathy, no organomegaly, and
no rash. Lumbar puncture revealed normal cerebrosp-
inal fluid indices and opening pressure. Magnetic reso-
nance imaging of the brain was notable for an increase
in signal intensity throughout the pons and upper
medulla lateralizing to the left of the midline (Figure 1).
Bartonella vinsonii subsp. berkhoffii was amplified and
sequenced directly from the initial EDTA-anti-coagu-
lated blood sample obtained from the father; however,
enrichment blood culture was PCR negative following a
7-day incubation period and a subculture (agar plate
maintained for 4 weeks) failed to result in bacterial
growth (Table 1). By IFA testing, the father was seror-
eactive to B. vinsonii subsp. berkhoffii genotypes II and
III and B. henselae antigens. Based upon these findings,
blood and cerebrospinal fluid were obtained for culture
in BAPGM approximately 3 weeks later, at which time
B. vinsonii subsp. berkhoffii was amplified and
sequenced from both 14 day blood and cerebrospinal
fluid enrichment cultures (7-day enrichment cultures
were again PCR negative). Seroreactivity to B. vinsonii
subsp. berkhoffii antigens remained essentially
unchanged (within one dilution of previous results);
however, there was a marked increase in the B. henselae
antibody titer. The father reported a history of
Figure 1 Cranial T2-weighted MRI showing mildly increased signal throughout the pons (circled), as well as in the upper medulla to
the left of midline. Also noted was mild diffuse atrophy and a few nonspecific foci of increased T2 signal seen in the frontal lobes.
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his illness. Sterile cotton swabs were used to obtain sal-
iva and periodontal surface samples, after which ITS-
PCR generated amplification products from both sam-
ples. Efforts to sequence the amplicon from saliva was
not successful; however, B. vinsonii subsp. berkhoffii was
amplified and sequenced from the periodontal swab. As
B. vinsonii subsp. berkhoffii DNA was identified in three
different sample sources (blood, CSF and periodontal
surface) and at three different time points in the labora-
tory, he was treated for bartonellosis with doxycycline
plus rifampin. During the first week of therapy he
reported a worsening of symptoms, followed by gradual
improvement. Following 3 weeks of antibiotics his B.
henselae antibody had titer decreased fourfold, his B.
vinsonii subsp. berkhoffii titers remained unchanged, and
B. henselae (ITS Houston I strain) was amplified and
sequenced from two 14-day BAPGM enrichment cul-
tures (both EDTA and ACD-anti-coagulated blood sam-
ples were independently processed). Based upon this
result, he received an additional 6 weeks of doxycycline
plus rifampin. During the subsequent 11 months, PCR
evidence of Bartonella infection was not detected in two
additional blood cultures, the patient became non-seror-
eactive B. henselae and B. vinsonii subsp. berkhoffii.
Post-treatment, the patient gradually regained body
weight and no longer experienced arthralgias or neuro-
logical symptoms.
Daughter
T h e71 / 2y e a ro l dd a u g h t e ro ft h ea b o v ep a t i e n tf i r s t
sought medical care for a similar constellation of symp-
toms in October, 2007. Her illness began suddenly one
morning with severe neck pain. Over the next month
the pain gradually improved but never fully remitted,
and she additionally developed headaches, low-grade
fevers, and general malaise. Her symptoms evolved to
include intermittent weakness of her legs and paresthe-
sias, which were so debilitating that she was no longer
able to attend school. She was seen by a pediatric neu-
rologist, and her vital signs and physical exam were
noted to be normal. She did not have any objective neu-
rologic deficits.
B a s e du p o np r i o rd e t e c t i o no fB. vinsonii subsp. ber-
khoffii in the father’s blood sample, a decision was made
to test the daughter. The daughter was seroreactive to
antigens of B. vinsonii subsp. berkhoffii genotypes II and
III and to B. henselae (Table 2). In addition, B. vinsonii
subsp. berkhoffii was amplified and sequenced from two
BAPGM blood cultures obtained approximately three
weeks apart. She was treated with a 6-week course of
azithromycin, after which there was a fourfold decrease
in the B. henselae antibody titer, though her B. vinsonii
subsp. berkhoffii antibody titers remained unchanged.
Despite initial symptomatic improvement, her symptoms
recrudesced towards the end of this antibiotic course. B.
vinsonii subsp. berkhoffii was again amplified and
sequenced from a 14-day BAPGM enrichment culture
and from the agar plate subculture (both the 7-day
enrichment culture and subculture were PCR negative).
She began a 9-week course of doxycycline, and at week
6, Bartonella spp. DNA was no longer detectable from
the extracted blood sample, from the BAPGM enrich-
ment blood culture, or from the agar plate. Due to con-
tinued intermittent neck and back pain the BAPGM
diagnostic platform was repeated approximately 6 weeks
later and a bacterial subculture isolate was obtained.
Because no product was amplified using the ITS pri-
mers, different primers were used. An Ochrobactrum sp.
was amplified and sequenced from a subculture isolate,
using primers targeting the RpoB gene. She remained
symptomatic while off therapy for the next two months,
Table 1 Serological, culture and molecular test results for a 50-year-old veterinarian (the father) with chronic weight
loss and progressive neurological dysfunction
Bartonella IFA Reciprocal Titers PCR/DNA Sequencing Results
Date/Sample (Father) B. henselae Bvb Genotype II Bvb Genotype III Direct Extraction BAPGM Enrichment Culture Subculture Isolate
10-18-07 Blood 512 32 256 Bvb TII Neg NIO
11-02-07 Blood 8192 64 128 Neg Bvb TII NIO
11-05-07 CSF NT NT NT Neg Bvb TII NIO
12-11-07 Oral Swab NT NT NT Bvb TII N/A N/A
1-18-08 Blood 1024 32 128 Neg Bh H1 NIO
5-27-08 Blood <16 16 16 Neg Neg NIO
11-04-08 Blood <16 <16 <16 Neg Neg NIO
Neg = DNA was not amplified using Bartonella 16S-23S intergenic spacer (ITS) primers.
NIO = No isolate obtained by subculture following BAPGM (Bartonella alpha Proteobacteria growth medium) enrichment culture.
N/A = Not applicable
NT = Not tested
BvbII = Bartonella vinsonii subsp. berkhoffii Genotype II by DNA sequencing
Bh H1 = Bartonella henselae ITS Houston I like strain by DNA sequencing
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persisted and she was retreated with a 6-week course of
doxycycline. During the subsequent two months anti-
body titers remained unchanged and two BAPGM blood
cultures failed to result in PCR detection of Bartonella
spp. infection. However, despite becoming seronegative
to all test antigens, B. henselae (Houston 1 strain) was
amplified and sequenced from a BAPGM enrichment
culture obtained 3 months later. She had a relapse of
neck pain several months later, but she did not receive
antibiotics that time. One year after testing was initiated,
the girl was no longer symptomatic and remained sero-
negative and blood culture negative. She suffered a
minor, unrelated head injury during this time. A CT
scan and subsequent MRI of the brain incidentally
revealed multiple curvilinear calcifications in the left
posterior parietal lobe along the periphery, throughout
the cerebrum in both the gray and white matter, and
sparing the cerebellum (Figure 2). These were thought
to represent calcifications, possibly consistent with a
prior granulomatous process. She was evaluated for
infections known to induce granulomas, (toxoplasmosis,
tuberculosis, histoplasmosis) but this workup was nega-
tive. The relationship of this radiographic finding to her
Bartonella spp. infection is unclear. She remained off
therapy, and has had no subsequent recurrence in symp-
toms during a 12-month follow-up period.
Other Family Members
Within the family, the mother and two sons were
reportedly healthy. As described for the father and
daughter, B. henselae and B. vinsonii subsp. berkhoffii
serology and BAPGM blood cultures were performed
for the mother (March, 2008) and for the two sons (Jan-
uary, 2008). In these three individuals, antibody titers
ranged from 1:32 to 1:128 to antigens of B. henselae and
B. vinsonii subsp. berkhoffii genotypes II and III. Barto-
nella spp. was not isolated nor PCR amplified from
blood or serum samples obtained from these three other
family members.
Family Pets
The family had four domestic shorthair cats and two
recently acquired one-year-old English Springer Spaniel
littermates. Two other dogs, previously owned by the
family, had been killed in an automobile accident, five
months prior to the onset of illness in the father and
daughter. All four cats had antibodies to B. henselae and
B. vinsonii subsp. berkhoffii antigens by IFA testing,
whereas antibodies were not detectable in serum sam-
ples from the two newly acquired dogs (Table 3). Barto-
nella henselae (ITS Houston 1 strain) was isolated from
three of four cats. By DNA sequencing, the B. henselae
ITS strains obtained from the father and daughter were
identical to each of the B. henselae ITS sequences
obtained from the three cats following direct extraction
from blood, following BAPGM enrichment culture, and
from agar plate derived isolates. The two English
Springer Spaniel littermates were PCR negative for Bar-
tonella spp. DNA following blood extraction, BAPGM
enrichment cultures and no bacteria were isolated.
Discussion
In this study, we report the simultaneous detection of B.
vinsonii subsp. berkhoffii infection in two family mem-
bers who were experiencing neurological dysfunction.
Bartonella vinsonii subsp. berkhoffii is an important
emerging intravascular pathogen that has been isolated
from patients with endocarditis, arthritis, neurological
disease and vasoproliferative neoplasia [5,6,14,15]. In the
current case report, both the father and daughter were
infected with B. vinsonii subsp. berkhoffii genotype II
Table 2 Serological, culture and molecular test results for a 7 1/2 -year-old girl (the daughter) with progressive
neurological dysfunction
Bartonella IFA Reciprocal Titers PCR/DNA Sequencing Results
Date/Sample
(Daughter)
B. henselae Bvb Genotype II Bvb Genotype III Direct Extraction BAPGM Enrichment Culture Subculture Isolate
11-07-07 Blood 256 <16 128 Neg Bvb TII NIO
11-28-07 Blood 256 <16 64 Neg Bvb TII NIO
1-11-08 Blood 64 32 32 Neg Bvb TII Bvb TII
3-20-08 Blood 64 32 32 Neg Neg NIO
5-08-08 Blood 64 16 16 Neg Neg Ochrobactrum sp.
6-24-08 Blood 64 32 16 Neg Neg NIO
7-31-08 Blood 16 32 64 Neg Neg NIO
10-13-08 Blood <16 <16 <16 Neg Bh H1 NIO
12-01-2008 Blood <16 <16 <16 Neg Neg NIO
Neg = DNA was not amplified using Bartonella 16S-23S intergenic spacer (ITS) primers.
NIO = No isolate obtained by subculture following BAPGM (Bartonella alpha Proteobacteria growth medium) enrichment culture. BvbII = Bartonella vinsonii subsp.
berkhoffii Genotype II by DNA sequencing
Bh H1 = Bartonella henselae ITS Houston I like strain by DNA sequencing
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infected with B. henselae. Considering the sequential
serological test results obtained for the father, it seems
likely that he was co-infected, when the first blood cul-
ture was obtained. Initial B. henselae antibody titers for
the father were 8 to 12 fold higher than the titers
obtained using B. vinsonii subsp. berkhoffii genotype II
antigens, whereas only a 6 fold difference was found in
the initial two serum samples from the daughter. As
there is a less convincing serological association
supporting co-infection in the daughter and as three of
four cats in the household were B. henselae bacteremic
during the period in which the father and daughter were
being treated for their B. vinsonii subsp. berkhoffii infec-
tions, it is possible that sequential infection with two
different Bartonella spp. was documented in the daugh-
ter during the course of this study. As the isolation and
molecular detection of these bacteria from patient sam-
ples remains microbiologically challenging, we were
unable to clearly establish whether either patient was
Table 3 Serological, culture and molecular test results for the household pets
Bartonella IFA Reciprocal Titers PCR/DNA Sequencing Results
Pet Designation B. henselae Bvb Genotype II Bvb Genotype III Direct Extraction BAPGM Enrichment Culture Subculture Isolate
JE Cat 512 128 64 Bh H1 Bh H1 Bh H1
CO Cat <16 128 <16 Bh H1 Bh H1 Bh H1
SN Cat 256 128 64 Neg Neg NIO
JA Cat 2048 2048 2048 Bh H1 Bh H1 Bh H1
TO Dog <16 <16 <16 Neg Neg NIO
EM Dog <16 <16 <16 Neg Neg NIO
Neg = DNA was not amplified using Bartonella 16S-23S intergenic spacer (ITS) primers.
NIO = No isolate obtained by subculture following BAPGM (Bartonella alpha Proteobacteria growth medium) pre-enrichment culture.
Bh H1 = Bartonella henselae ITS Houston I like strain by DNA sequencing
Figure 2 Axial T2-weighted MRI of the daughter showing multiple, very small calcifications throughout the cerebrum in both white
and gray matter, sparing the cerebellum. These lesions were felt to be most consistent with a prior, inactive granulomatous process.
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points.
Previously, we described the preferential amplification
of one Bartonella sp. when two or more species are pre-
sent in the extracted sample [16]. The mechanism(s)
responsible for preferential amplification of one bacteria
when DNA of two species is present in a patient sample
is unclear, but mechanisms could include the relative
concentrations of DNA of the respective organisms in
the sample at the time of DNA extraction for PCR
amplification, or selective amplification of one DNA
sequence over the other one, when comparable template
concentrations are present. Targeting multiple Barto-
nella genes can enhance the possibility of detecting co-
infection in patient samples [17-19]. Potentially, PCR
primers targeting different gene fragments preferentially
amplify different Bartonella spp. in co-infected indivi-
duals. It is also possible that BAPGM enrichment cul-
ture preferentially selects for the growth of one
Bartonella spp. in a co-infected individual. Therefore
both individuals may have been co-infected with B. vin-
sonii subsp. berkhoffii and B. henselae at the outset of
this study.
As the sequences of the B. henselae strains obtained
from the father and daughter’s blood cultures were iden-
tical (B. henselae ITS strain Houston1) to the blood cul-
ture strains obtained from the three cats, the family cats
were the presumed source of this infection.
Although the mother and two sons were healthy and
blood culture negative when tested on a single occasion,
all three had serological evidence supporting prior expo-
sure to B. henselae. The two newly acquired young dogs
were not seroreactive to Bartonella antigens and both
were blood culture negative; therefore it seems unlikely
that these dogs played a role in transmission of B. hen-
selae or B. vinsonii subsp. berkhoffii in the family.
Although cats are the primary reservoir host, B. henselae
has been isolated by blood culture from dogs and
sequenced from dog saliva [8,9]. It is possible that an
arthropods or the two older dogs that had died prior to
initiation of this study were the source of B. vinsonii
subsp. berkhoffii infection, as historically this organism
has been isolated from domestic and wild canines and
humans [1,2]. Infection with B. vinsonii subsp. berkhoffii
was recently described in a cat with recurrent osteomye-
litis that was bacteremic over a 15-month time period
[20]. Therefore, cats may be able to maintain a persis-
tent B. vinsonii subsp. berkhoffii bacteremia and poten-
tially serve as a source of bacterial transmission to
humans [14]. Efforts to amplify B. vinsonii subsp. ber-
khoffii from the cats in this study using subspecies-spe-
cific primers were not successful. Over 100 years ago, B.
quintana was transmitted to human volunteers, when
saliva from a febrile patient was applied to escharified
skin [21]. As saliva obtained from soldiers with trench
fever apparently contains viable, infectious Bartonella
quintana, oral transmission of B. vinsonii subsp. berkhof-
fii from the father or a pet cat to the daughter through
close family contact cannot be ruled out. Bartonella spp.
DNA has now been reported in the saliva of cats, dogs
and humans [22,23]. Clearly, additional data is needed
to define the risk factors for Bartonella spp. transmis-
sion to humans and to their pets, but it seems prudent
to recommend hygienic measures after contacting pet
and perhaps human saliva.
The father in this report is the second patient in
which enrichment culture enhanced the molecular
detection of a Bartonella spp. in cerebrospinal fluid. In
a previous study, B. henselae was repeatedly detected by
blood or cerebrospinal fluid culture in a 23 year-old girl
who developed progressively severe seizures following a
history of cat scratch disease [6]. In both patients, cere-
brospinal fluid analyses were reported to be within nor-
mal limits; however, inadvertent contamination of the
sample with blood cells cannot be ruled out. As Barto-
nella spp. appear to target vascular endothelial cells, it is
possible that B. vinsonii subsp. berkhoffii and B. henselae
contributed to the nonspecific area of vascular injury
reported on the father’s MRI.
The use of an optimized insect-based cell culture
growth medium can facilitate the isolation or enhanced
molecular detection of Bartonella spp. following cul-
ture-enrichment of patient samples prior to performing
PCR [5,6,8,14,18]. The enhanced diagnostic utility of the
enrichment approach is best illustrated in Table 2,
where B. vinsonii subsp. berkhoffii and B. henselae DNA
were never directly amplified from extracted blood sam-
ples obtained from the daughter and were only detect-
able by PCR following enrichment culture. In our
experience, at least a 7 to 14-day incubation period is
required before the enriched sample is obtained from
liquid BAPGM for DNA extraction. At no time during
this study was Bartonella spp. DNA amplified from a
DNA extraction control, a BAPGM un-inoculated
enrichment culture control or a subculture agar plate
control. Although not detailed in the table, it is not
unusual for 7-day enrichment cultures and subcultures
to be PCR negative for Bartonella spp. DNA, whereas
the respective organism can be amplified and sequenced
after a 14-day incubation period from the enriched
liquid culture, the agar plate isolate, or both. Due to the
high level of B. henselae bacteremia generally found in
cats, the same strain could be detected in each cat fol-
lowing direct extraction of the blood sample, enrich-
ment culture and the agar plate isolates (Table 3).
Unfortunately, despite the enhanced utility of enrich-
ment culture for the molecular microbiological diagnosis
of Bartonella infection, obtaining viable agar plate
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days post-incubation remains technically difficult. In this
study, only one B. vinsonii subsp. berkhoffii isolate was
o b t a i n e df r o mt h ed a u g h t e r ’s post-antibiotic blood cul-
ture after a 14-day enrichment period, whereas the 7-
day BAPGM enrichment culture and subculture were
both PCR negative. An isolate was never obtained from
the father; however as described above, using the same
BAPGM enrichment platform, B. henselae isolates were
obtained from three of the four cats in the household.
As overtly healthy cats can maintain a high-level of bac-
teria in systemic circulation for months to years, isola-
tion of B. henselae form cat blood samples is
comparatively easy to achieve, as compared to isolation
using the same approaches from dog or human blood
samples [11,12]. Failure to obtain stable Bartonella iso-
lates is a major patient management limitation, as it pre-
vents routine testing for antibiotic sensitivity and
resistance of specific isolates at time points prior to and
following antibiotic administration. This was of particu-
lar concern for these two patients, as B. henselae DNA
was still sequenced from an enrichment culture of the
father’s blood following a 3-week course of doxycycline
and rifampin and B. vinsonii subsp. berkhoffii was
detected in the girl’s blood following a 6-week course of
azithromycin. Based upon negative post-antibiotic blood
cultures and a decremental decrease in antibody titers
to non-detectable levels, antibiotic treatment appeared
to correlate with microbiological elimination of B. vinso-
nii subsp. berkhoffii and B. henselae infections, cessation
of antibody production, and with the eventual clinical
resolution of illness in both patients.
The father reported a recent history of severe period-
ontal disease. Two previous molecular microbiological
studies identified Bartonella spp. DNA in subgingival
samples from patients with periodontitis. [24,25]. In
addition, other investigators have detected B. henselae
DNA and B. quintana DNA in the parotid salivary
glands of an immunocompetent woman and man,
respectively and B. quintana in the dental pulp of a
homeless man [26-28]. After which B. vinsonii subsp.
berkhoffii genotype II was successfully sequenced from
the periodontal swab, but attempts to sequence the
amplicon obtained from the salivary swab were not suc-
cessful (Table 1). As identical techniques were used, this
result might be explained by a higher concentration of
B. vinsonii subsp. berkhoffii DNA at the periodontal sur-
face, as compared to dilution of bacterial DNA targets
floating in saliva in the oral cavity. In our laboratory, a
B. henselae SA2 strain (2.5 copies/reaction) is used as
the source of positive control DNA for the ITS PCR
reaction; therefore, contamination with positive control
DNA could not explain any PCR results obtained in
these two patients. As over 500 species of bacteria have
been estimated to inhabit the oral cavity, BAPGM
enrichment culture was not attempted because rapidly
growing organisms would negate efforts to increase Bar-
tonella numbers via the enrichment process [29,30]. It is
also possible that detection of B. vinsonii subsp. berkhof-
fii in close approximation of the periodontal surface
reflects passive leakage of bacteria through inflamed and
compromised vascular tissues or alternatively the estab-
lishment of an active foci of infection that contributed
to the recent history of periodontitis. Detection of DNA
in the oral cavity does not confirm the presence of
viable bacteria; however, caution should be exercised by
dentists and physicians when examining the oral cavity
of an individual with chronic Bartonella spp. bacteremia.
Conclusions
B. vinsonii subsp. berkhoffii and B. henselae are zoonotic
pathogens that can be isolated from the blood of immu-
nocompetent family members with arthralgias, fatigue
and neurological symptoms. Therapeutic elimination of
Bartonella spp. infections can be challenging, and fol-
low-up testing is recommended. An increasing number
of arthropod vectors, including biting flies, fleas, keds,
lice, sandflies and ticks have been confirmed or are sus-
pected as the primary mode of transmission of Barto-
nella species among animal populations and may also
pose a risk to human beings.
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